Drug intelligence / Profile preview

citral nanoliposome

Development stage
Preclinical
Modality
Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral, Topical, Transdermal, Vaginal, Intravenous, Parenteral
01

Overview

Citral nanoliposome is a lipid-based nanoformulation of citral (3,7-dimethyl-2,6-octadienal), a natural acyclic monoterpene aldehyde found in essential oils such as lemongrass. This formulation is being investigated for its neuroprotective, anti-inflammatory, and antioxidant properties, particularly in the context of neurodegenerative disorders like Parkinson's disease. The nanoliposomal delivery system is designed to enhance the stability and bioavailability of citral, potentially facilitating its transport across the blood-brain barrier. Preclinical studies in rat models have demonstrated that citral nanoliposome can modulate oxidative stress by reducing lipid peroxidation (LPO) and increasing the activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). Furthermore, it exhibits anti-inflammatory effects by suppressing the expression of pro-inflammatory markers, including TNF-α, IL-6, and NF-κB, while upregulating brain-derived neurotrophic factor (BDNF), which supports neuronal survival and behavioral recovery.

Other names
nanoliposome-coated citralliposomal citral
02

Targets

GPX4 (Glutathione peroxidase 4)IL-6 (Interleukin 6)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)Misfolded SOD1TNFA (Tumor necrosis factor alpha (soluble))NF-κB

Beyond the preview

Go deeper on citral nanoliposome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citral nanoliposome.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call